Cargando…
Immunomodulation in the Treatment of Refractory Catastrophic Antiphospholipid Syndrome
Catastrophic antiphospholipid syndrome is a rare condition with high morbidity and mortality. We present a refractory case of catastrophic antiphospholipid syndrome with a view to highlight the importance of early identification and aggressive treatment of this condition. A 36-year-old female presen...
Autores principales: | Nath, Karthik, McCann, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902127/ https://www.ncbi.nlm.nih.gov/pubmed/29805821 http://dx.doi.org/10.1155/2018/1041396 |
Ejemplares similares
-
Catastrophic Antiphospholipid Syndrome
por: El-Shereef, Rawhya R., et al.
Publicado: (2016) -
Plasma Exchange in the Management of Catastrophic Antiphospholipid Syndrome
por: Titeca-Beauport, Dimitri, et al.
Publicado: (2016) -
Secondary vasculopathy due to catastrophic antiphospholipid syndrome
por: Bezerra, Alexandre Sacchetti, et al.
Publicado: (2023) -
A Rare Case of Refractory Catastrophic Antiphospholipid Syndrome Successfully Treated With Rituximab and Plasma Exchange
por: Bangolo, Ayrton, et al.
Publicado: (2023) -
Primary Refractory Catastrophic Antiphospholipid Syndrome Masquerading as Buerger’s Disease
por: Tannous, Toufic, et al.
Publicado: (2021)